Increasing, or maintaining, physical activity levels, where possible: A doctor should be able to provide advice on how to create and stick to a healthy exercise routine.Instead, people should limit their sodium intake to less than 2,300 milligrams per day. The body needs some sodium to function, so it is important to not eliminate it from the diet. Reducing the amount of salt in the diet: High-sodium foods include prepackaged, fried, and processed foods, such as prepared meals and potato chips.A person can adopt the following measures: Lifestyle adjustmentsįor people living with heart failure, behavioral changes can make a significant difference in their quality of life. Most people require the ongoing support of a cardiologist and some may need to take heart medication for the rest of their lives. doi: 10.1002/ failure is a life threatening medical condition that a person cannot treat with home remedies or lifestyle changes alone. The use of diuretics in heart failure with congestion - a position statement from the Heart Failure Association of the European Society of Cardiology. Mullens W, Damman K, Harjola VP, Mebazaa A, Brunner-La Rocca HP, Martens P, et al. Diuretic therapy for patients with heart failure: JACC state-of-the-art review. doi: 10.1093/eurheartj/ehab368.įelker GM, Ellison DH, Mullens W, Cox ZL, Testani JM. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, et al. Issue - 2047-4881 (Electronic) Pages T - ppublish. Burden of heart failure and underlying causes in 195 countries and territories. NL B, Id- Orcid X, W Z, J S, A AM, D L, et al. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, et al. Tolvaptan can be recommended for water retention in HF patients, but more evidence is needed.ĪMSTAR-2 GRADE Heart failure Overview Tolvaptan Water retention. The result of GRADE assessment was not optimistic, so the overall quality of the evidences was low as well. Besides, every article had a few non-critical item defects too. all the 9 articles were rated as low-quality because AMSTAR 2 evaluation showed that they each had at least one critical item (items 2, 4, 7, 9, 11, 13 and 15) defect. It was pessimistic when it comes to the quality of the 9 studies. Through conducting forest plots, it appeared that tolvaptan brought more positive effect than conventional therapies. Serum sodium concentration and urine output were considered as primary outcomes and body weight change and all-cause mortality as second outcomes. The methodological and evidence quality were respectively evaluated by AMSTAR-2 (A MeaSurement Tool to Assess systematic Reviews 2) and GRADE (Grading of Recommendation of Assessment, Development, and Evaluation) system.Ī total of 9 SRs/Mas between 2015 to 2020 met inclusion criteria. Revman 5.3 was used to make forest plots to show the characteristics of outcomes. Standardized forms were used to extract data. All the records were managed with Endnote 20. The purpose of this systematic review is to collect, appraise, and synthesize existing evidence from systematic reviews and meta-analyses (SRs/MAs) on the effectiveness of tolvaptan for water retention in heart failure.Ī comprehensive literature search was performed on PubMed, EMBASE, web of science, Cochrane reviews for SRs/Mas published between the databases' establishment to November 17, 2021.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |